What Happened? Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) jumped 4.5% in the afternoon ...

Genomics company Pacific Biosciences of California (NASDAQ:PACB) fell short of the markets revenue expectations in Q3 CY2025, with sales falling 3.8% year on year to $38.44 million. Its non-GAAP loss ...

Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) fell 7.5% in the afternoon session after the market continued to react negatively to the company's third-quarter financial ...

PacBio's financials for 2023 show significant growth, with revenue more than doubling in Q4 and a 56% increase in annual revenue compared to the previous year. The company's product innovations, such ...

(RTTNews) - PacBio (PACB), a developer of highly accurate sequencing solutions, is slated to participate in several upcoming investor conferences this month, underscoring its visibility within the ...

PacBio, a leading developer of high-quality, highly accurate sequencing solutions today announced a clinical research study with Radboud University Medical Center (Radboudumc) to explore genetic ...

Appointment of David Ruggiero as Global Head of Sales & Service highlights the company's commitment to strengthening its leadership team with experienced professionals. Mr. Ruggiero brings over two ...

Gross margin, operating expenses, net loss, and net loss per share are reported on a GAAP and non-GAAP basis. The non-GAAP measures are described below and reconciled to the corresponding GAAP ...

When GEN spoke with Christian Henry, CEO of PacBio, before last year’s American Society of Human Genetics (ASHG) conference being held in Los Angeles, his excitement was palpable. The company was ...